News | FFR Technologies | July 26, 2018

Updated SCAI Expert Consensus Says Either FFR, iFR Can Be Used

iFR reference numbers posted for new users in the cath lab at Northwestern Medicine's Central DuPage Hospital in Winfield, Ill.

July 26, 2018 — The Society of Cardiac Angiography and Interventions (SCAI) released a focused update expert consensus statement in July for the use of invasive coronary physiological assessments. It recommends either fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR) technologies can be used to assess the hemodynamic significance of coronary lesions to determine if a stent is needed. The statement said physiologicaly guided percutaneous coronary intervention (PCI) results in better clinical outcomes and saves resources compared to angiographic image guidance alone.[1] 

Both iFR and FFR are deemed “definitely beneficial” for assessing the functional significance of intermediate coronary stenoses when noninvasive stress imaging is not available or does not provide a definitive answer. SCAI sees probable benefits when FFR or iFR are used to reclassify the number of vessels that are diseased in patients with multivessel disease.

SCAI’s updated consensus statement was published in the SCAI journal Catherization and Cardiovascular Interventions. Based on the data from the DEFINE-FLAIR and iFR Swedeheart trials showing that the technique is noninferior to FFR for guiding decisions about intervening on intermediate lesions in patients with stable angina or non-STEMI acute coronary syndrome (ACS).[2,3]

The authors also spend some time covering the utility of iFR and/or FFR in stable ischemic heart disease, multivessel coronary artery disease (CAD), left main coronary stenosis, ACS, STEMI, aortic stenosis, tandem and serial lesions, and bypass grafts.

Access the expert consensus statement article. 

 

Related FFR and iFR Content:

What is New in FFR Technology

VIDEO: iFR Equal to FFR Outcomes in Coronary Lesion Evaluation

ORBITA: FFR and iFR as Predictors Placebo-controlled Response to PCI

VIDEO: iFR Found More Cost Effective Over Standard FFR

 

References: 

1. Amir Lotfi, Justin E. Davies, William F. Fearon, et al. Focused update of expert consensus statement: Use of invasive assessments of coronary physiology and structure: A position statement of the society of cardiac angiography and interventions, First published: 03 July 2018 https://doi.org/10.1002/ccd.27672

2. Justin E. Davies, Sayan Sen, Hakim-Moulay Dehbi, et al. Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI, N Engl J Med 2017; 376:1824-1834. DOI: 10.1056/NEJMoa1700445

3. Matthias Götberg, Evald H. Christiansen, Ingibjörg J. Gudmundsdottir, et al.  Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI. N Engl J Med 2017; 376:1813-1823. DOI: 10.1056/NEJMoa1616540
 


Related Content

News | Cath Lab

May 31, 2022 — Innovative Health, LLC, a specialty cardiology reprocessor, announced that the company has received ...

Home May 31, 2022
Home
News | Cath Lab

May 26, 2022 — The U.S. Food and Drug Administration (FDA) has recalled the Dragonfly OpStar Imaging Catheter, and has ...

Home May 26, 2022
Home
News | Cath Lab
April 25, 2022 – NewYork-Presbyterian Hudson Valley Hospital celebrated the launch of its interventional cardiology ...
Home April 25, 2022
Home
News | Cath Lab
April 18, 2022 – Royal Philips and Oulu University Hospital (Finland) have announced a strategic 10-year partnership ...
Home April 18, 2022
Home
News | Cath Lab
February 16, 2022 – Fremont Bank Foundation recently donated $750,000 to its community partner, St. Rose Hospital ...
Home February 16, 2022
Home
News | Cath Lab
February 14, 2022 — A collaborative effort between The Valley Heart and Vascular Institute’s cardiology team ...
Home February 14, 2022
Home
Sponsored Content | Videos | Cath Lab

Advancements in analytics and data visualizations are helping to streamline operations and improve productivity at cath ...

Home January 13, 2022
Home
News | Cath Lab

January 4, 2022 — The U.S. Food and Drug Administration (FDA) has authorized marketing of the first laser-based device ...

Home January 04, 2022
Home
News | Cath Lab

December 14, 2021 — RSIP Vision, a medical imaging company applying advanced artificial intelligence (AI) and computer ...

Home December 14, 2021
Home
Feature | Cath Lab

November 15, 2021 — RealView Imaging Ltd. recently received FDA 510(k) clearance for its Holoscope-i holographic system ...

Home November 15, 2021
Home
Subscribe Now